We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MJFF

News List

MapLight Therapeutics Receives Grant for Parkinson's Disease Research americanpharmaceuticalreview
December 16, 2020
MapLight Therapeutics announced a $8.1 million grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF), to undertake a large-scale, systematic investigation of the brain circuits and mechanisms that are responsible for triggering ...
Amydis Receives Grant to Accelerate Development of Alpha-Synuclein Retinal Tracer americanpharmaceuticalreview
August 14, 2020
Amydis has received a new grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for the Company’s pioneering retinal tracer program for alpha-synuclein (ASYN).
Parkinson's Therapy Funded by NJFF Receives FDA Approval, Advances to Market americanpharmaceuticalreview
June 01, 2020
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces a milestone in the Foundation's impact on the Parkinson's disease (PD) therapeutic landscape.